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Increasing evidence suggests that tissue transglu-
taminase (tTGase; type II) is externalized from cells,
where it may play a key role in cell attachment and
spreading and in the stabilization of the extracellular
matrix (ECM) through protein cross-linking. However,
the relationship between these different functions and
the enzyme’s mechanism of secretion is not fully under-
stood. We have investigated the role of tTGase in cell
migration using two stably transfected fibroblast cell
lines in which expression of tTGase in its active and
inactive (C277S mutant) states is inducible through the
tetracycline-regulated system. Cells overexpressing
both forms of tTGase showed increased cell attachment
and decreased cell migration on fibronectin. Both forms
of the enzyme could be detected on the cell surface, but
only the clone overexpressing catalytically active
tTGase deposited the enzyme into the ECM and cell
growth medium. Cells overexpressing the inactive form
of tTGase did not deposit the enzyme into the ECM or
secrete it into the cell culture medium. Similar results
were obtained when cells were transfected with tTGase
mutated at Tyr274 (Y274A), the proposed site for the cis-
,trans peptide bond, suggesting that tTGase activity
and/or its tertiary conformation dependent on this bond
may be essential for its externalization mechanism.
These results indicate that tTGase regulates cell motil-
ity as a novel cell-surface adhesion protein rather than
as a matrix-cross-linking enzyme. They also provide fur-
ther important insights into the mechanism of external-
ization of the enzyme into the extracellular matrix.
Transglutaminases (EC 2.3.2.13) are a group of Ca2-de-
pendent enzymes that catalyze the post-translational modifi-
cation of proteins through the incorporation of primary amines
into the -carboxamide group of glutamine residues or by the
cross-linking of proteins via -(-glutamyl)lysine bridges (1).
Proteins cross-linked as a result of transglutaminase-catalyzed
reactions are generally more resistant to mechanical, chemical,
and proteolytic breakdown. Tissue transglutaminase (tTGase1;
type II) is the most widely distributed form of transglutami-
nase in mammalian tissues (1). In addition to its ability to
cross-link proteins, the enzyme can also bind and hydrolyze
GTP and ATP (2, 3). Binding of GTP/GDP to the enzyme is
thought to increase the tTGase tertiary structure stability and
in a viable cell keeps the enzyme inactive as a transglutami-
nase (4). It has been reported that Ca2 and GTP induce
opposite conformational changes in the protein tertiary struc-
ture, therefore suggesting that the mechanism by which
tTGase activity is inhibited by GTP/GDP is essentially due to a
protein conformational change that obscures access to the
transglutaminase active site (5). More recent work has also
suggested that a non-proline cis peptide bond close to the
active-site cysteine (Cys277) may play a role in the conforma-
tional changes linked to the binding of Ca2 and/or substrate
during activation of the enzyme (6).
The ability of tTGase to create covalent protein cross-links
suggests its involvement in maintaining tissue integrity; and
as a consequence, the enzyme is thought to play an important
role in various physiological as well as pathological situations
such as wound healing, fibrosis, inflammation, and tumor me-
tastasis (7–11). Although tTGase was originally thought to be
an intracellular enzyme, accumulating evidence indicates that
the enzyme is externalized and capable of cross-linking a wide
range of extracellular matrix (ECM) proteins, which is thought
to be important in ECM deposition/stabilization and the cell
attachment and spreading of a number of different cell types
(12–15). However, the link between ECM cross-linking and the
role of the enzyme in cell attachment and spreading is still not
fully understood. Also unknown is the mechanism of secretion
of the enzyme from cells because tTGase does not possess a
leader sequence, and there is no evidence of its glycosylation
(1). It is therefore unlikely that the enzyme follows the classical
endoplasmic reticulum-Golgi secretion route. Despite this ob-
servation, evidence for the presence of tTGase in the ECM and
on the surface of different cell types is now increasing (12–19).
It has been recently described that tTGase mediates cell ad-
hesion and spreading by a mechanism that is independent of its
catalytic activity (20). The mechanism proposed suggests that
tTGase mediates the interaction of integrins with fibronectin,
thereby acting as an integrin-associated co-receptor (15). The
results from the latter study suggested that complexes of tTGase
with integrins are formed inside the cell during biosynthesis,
leading to its accumulation on the surface at sites of focal adhe-
sion points (15). It has also been demonstrated that in cells
undergoing attachment and spreading, the enzyme is co-
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distributed with adhesion site markers, suggesting that these
processes may coincide with the externalization of the enzyme
(21).
tTGase has a high affinity binding site for fibronectin that is
localized to the first seven N-terminal amino acids (22); and
this binding is independent of its cross-linking activity. The
deletion of this N-terminal sequence from the tTGase gene
abolishes binding of the enzyme to fibronectin and prevents its
cell-surface localization, suggesting that secretion of tTGase
from the cells could be associated with the assembly of fibronec-
tin fibrils (23). Other proteins lacking the classical signal se-
quence but efficiently secreted from the cells have been de-
scribed to cross the membrane by a novel secretion pathway
(24–27); but in most cases, the exact mechanism is still not
fully understood.
Because tTGase is involved in both cell attachment and
spreading and, through its cross-linking activity, in wound
healing and tissue fibrosis (7–11, 28), it is not unreasonable to
assume that it might also be involved in cell migration, a
process that is important to a number of cellular events, in-
cluding embryogenesis, tissue repair, and tumor invasion. To
explore this, we have used 3T3 fibroblasts transfected with a
number of different tTGase constructs expressing the catalyt-
ically active or inactive forms of tTGase. We show that tTGase
can regulate migration and that this novel function is inde-
pendent of its cross-linking activity. We also demonstrate that
mutation of the active-site cysteine prevents the enzyme from
being deposited into the ECM and that mutation of Tyr274 to
Ala, thought to provide cis rather than the preferred trans
peptide bond conformation, also leads to loss of tTGase activity
and of enzyme secretion. We therefore conclude that tTGase
controls cell motility by a process that does not require its
deposition into and cross-linking of the ECM, but by acting as
a novel cell-surface binding protein.
EXPERIMENTAL PROCEDURES
Chemicals—All general chemicals and tissue culture reagents were
obtained from Sigma (Dorset, UK) unless otherwise stated.
PCR Mutagenesis—The C277S mutation was introduced into tTGase
cDNA (29) as previously described (30). The resulting mutant tTGase
cDNA was inserted into the vector pUHD10.3 (14) to generate the
expression plasmid pUHD10.3-TG277.
The Y274A mutation was introduced into tTGase cDNA using the
GeneEditor in vitro site-directed mutagenesis kit (Promega, Southamp-
ton, UK) according to the manufacturer’s protocol. Starting with the
expression vector pSG5-TG containing the full-length tTGase cDNA
(donated by P. J. A. Davies, University of Texas Health Center, Hous-
ton, TX), the TAT codon of Tyr274 was mutated to GCT for Ala utilizing
the oligonucleotide primer 5-AAGACCCAGCACTGGCCAGCCTTGAC-
GCGCTGGCA-3 (antisense orientation), which is complementary to
nucleotides 940–974 of tTGase cDNA (29) and is mutated at positions
955 and 956 (underlined). The resulting recombinant plasmid encoding
mutant tTGase was named pSG5-TG274. The presence of the base
changes was confirmed by DNA sequencing.
Transfections—The establishment, by cell transfection, of Swiss 3T3
cell lines expressing catalytically active tTGase under the control of the
tetracycline-regulated system (31) has been previously described (14).
Swiss 3T3 cell lines expressing inactive C277S mutant tTGase were
generated following the same protocol. Briefly, clone tTA2, stably ex-
pressing the tetracycline-controlled transactivator (14), was cotrans-
fected with pUHD10.3-TG277 and the xanthine-guanine phosphoribo-
syltransferase expression plasmid pUS1000 (donated by P. Sanders,
University of Surrey) in the presence of tetracycline in the medium.
Clones resistant to selection medium for the salvage enzyme xanthine-
guanine phosphoribosyltransferase were analyzed for their capacity to
overexpress tTGase antigen by standard Western blotting of cell
homogenates using anti-tTGase monoclonal antibody Cub7402
(Neomarkers).
Transfection of Swiss 3T3 fibroblasts with wild-type and inactive
Y274A mutant tTGases was achieved by cotransfecting 0.5  106 cells
with 4.5 g of plasmid vector pSG5-TG274 and 0.5 g of selection vector
pSV2neo using the liposome-based transfection reagent ESCORT
TM
(Sigma) following the manufacturer’s protocol. Clones resistant to 800
g/ml active G418 (Geneticin, Calbiochem) were screened for overex-
pression of tTGase by Western blotting as described below.
Cell Culture—Cell lines of Swiss 3T3 fibroblasts expressing catalyt-
ically active tTGase (clone TG3) (14) or inactive C277S mutant tTGase
(clone TGI19) in a tetracycline-regulated manner were cultured as
described (14). Cell lines were continuously cultured in the presence of
tetracycline (2 g/ml) in the medium. Under this condition, they ex-
pressed only low levels of endogenous tTGase. To induce maximum
expression of transfected tTGase cDNA, cells were cultured in the
absence of tetracycline for 72 h. Cell lines of Swiss 3T3 fibroblasts
(clones TG1, TG16, TGY274A1, TGY274A2, neo1, and neo3) expressing
active or inactive Y274A mutant tTGase or the selection marker for
G418 resistance, under the control of a non-inducible promoter, were
grown in Dulbecco’s modified Eagle’s medium containing 10% heat-
inactivated fetal calf serum, 2 mM glutamine, 100 units/ml penicillin,
100 g/ml streptomycin, and 400 g/ml G418.
Cell Migration—The cell migration assay used was a modification of
the technique described by Akiyama et al. (32). Low-melting-point aga-
rose (0.2% (w/v) final concentration), maintained just above 38 °C, was
added to a suspension of cells (3.3  107 cells/ml) in bicarbonate-free
Dulbecco’s modified Eagle’s medium (buffered with 25 mM Hepes, pH
7.4). Droplets (0.5 l) of the cell/agarose mixture were seeded in the
center of the fibronectin (15 g/ml)-coated wells of a 96-well plate. After
the agarose was allowed to set for 7 min at 4 °C, 100 l of the growth
medium was added to each well. In some cases, the growth medium was
supplemented with anti-tTGase antibody or tTGase inhibitors. Cells
were left to migrate for 48 h and then fixed and stained with 0.5% (w/v)
crystal violet in 70% (w/v) ethanol as described below. The area of
outwardly migrating cells was measured using an Optimas 5.2 image
analysis system (DataCell Ltd., Yately, UK).
Cell Attachment—Cell attachment was evaluated as previously de-
scribed (13). Briefly, 100 l of a cell suspension (5  105 cells/ml) was
seeded in a 96-well plate coated with 5 g/ml fibronectin, incubated in
serum-free medium, and allowed to attach for 30 min. After this, the
cells were gently washed with phosphate-buffered saline (PBS), and
attached cells were fixed and stained by addition of 0.5% (w/v) crystal
violet in 70% (v/v) ethanol at 100 l/well. Following three washes with
PBS to remove nonspecific staining, cells were solubilized by adding
30% (v/v) acetic acid at 100 l/well. The absorbance of the solubilized
cell mixture was read at 540 nm in a SpectraFluor plate reader (Tecan).
Transglutaminase Activity Assay—The activity of tTGase in cell ho-
mogenates was measured by the incorporation of 14C-labeled putrescine
(Amersham Biosciences, Buckinghamshire, UK) into N,N-dimethylca-
sein as previously described by Lorand et al. (33). One unit of tTGase
activity equals 1 nmol of putrescine incorporated per h. The activity of
tTGase associated with the extracellular surface of live cells in culture
was measured by the incorporation of biotinylated cadaverine into
deoxycholate-insoluble fibronectin using an assay described in detail by
Jones et al. (13).
Detection of tTGase in Cell Fractions and Growth Medium—For
detection of tTGase in cell homogenates, after cell lysis in ice-cold buffer
(0.25 M sucrose, 2 mM EDTA, and 5 mM Tris-HCl, pH 7.4) containing
protease inhibitors (1 g/ml pepstatin, 1 g/ml leupeptin, and 1 mM
phenylmethylsulfonyl fluoride) and sonication, cell homogenates were
mixed with 2 Laemmli loading buffer (34) and boiled for 5 min at
100 °C, and then proteins were resolved as described below. For sepa-
ration of membrane and cytosolic fractions, cell homogenates were first
fractionated by ultracentrifugation at 100,000  g for 1 h at 4 °C. The
precipitated pellets were washed once with the cell lysis buffer and
centrifuged as described above. Proteins were resolved by SDS-PAGE
under reducing conditions according to Laemmli (34), and tTGase was
detected by Western blotting using anti-tTGase monoclonal antibody
Cub7402 and revealed by enhanced chemiluminescence (Amersham
Biosciences) after incubation with an anti-mouse horseradish peroxi-
dase conjugate. For direct comparison of cell homogenates or subcellu-
lar fractions, equal amounts of protein were loaded onto the gels prior
to fractionation.
To detect tTGase secreted into the growth medium, confluent cells
were grown in serum-free AIMV culture medium (Gibco) for 8 h. The
medium was then collected and centrifuged to remove any floating cells.
Proteins from the cell growth medium were precipitated by addition of
trichloroacetic acid to a final concentration of 10% (w/v), followed by
centrifugation. The protein pellet was washed once with 10% (w/v)
trichloroacetic acid followed by ethanol/acetone (1:1) and acetone, dried,
and resuspended in Laemmli buffer (34). The presence of tTGase in the
protein pellet was detected by Western blotting as outlined above.
Alternatively, the cell growth medium was lyophilized, reconstituted in
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one-tenth of the initial volume, and analyzed for tTGase antigen by a
modified enzyme-linked immunosorbent assay (ELISA) method accord-
ing to Achyuthan et al. (35) as described below. The protein concentra-
tion was determined according to the method of Lowry et al. (36).
Measurement of tTGase by Modified ELISA—Detection of extracel-
lular tTGase was performed using the modified ELISA technique de-
scribed previously (19). Briefly, 1.5  104 cells/well were seeded in a
96-well plate 1 day prior to the assay. Anti-tTGase antibody Cub7402
was diluted 1:1000 in the cell growth medium and added directly to cells
in live culture. After a 3-h incubation, cells were washed with PBS and
fixed in methanol. The antigen-antibody complex was revealed by in-
cubation with horseradish peroxidase-conjugated anti-mouse IgG sec-
ondary antibody. Bound horseradish peroxidase activity was detected
by addition of 3,3,5,5-tetramethylbenzidine substrate. Color develop-
ment was stopped with 2.5 N H2SO4, and the absorbance was read at
450 nm in a plate reader. For protein quantification, identical cell
numbers were grown in parallel and solubilized in 0.1% (w/v) deoxy-
cholate. Proteins were precipitated in 10% (w/v) trichloroacetic acid and
assayed by the bicinchoninic acid method (37). The measured tTGase
protein was then expressed as A450 nm/1.0 mg of deoxycholate-soluble
protein.
For detection of total tTGase, a modification of the method of
Achyuthan et al. (35) was used. Cell homogenates were added to the
fibronectin-coated wells of a 96-well plate, and the binding of tTGase to
fibronectin was allowed to proceed for 1 h at 37 °C. Wells were then
blocked with blocking buffer (5% (w/v) dried skimmed milk in PBS, pH
7.4) and incubated with Cub7402 (diluted 1:1000 in blocking buffer) for
2 h at room temperature. After three washes with PBS, incubation with
horseradish peroxidase-conjugated anti-mouse IgG secondary antibody
(diluted 1:1000 in blocking buffer) was carried out for 2 h at room
temperature. Bound horseradish peroxidase activity was measured as
described above. The amount of tTGase protein was expressed as
A450 nm/1.0 mg of total protein.
Immunohistochemical Staining for Extracellular tTGase—Detection
of extracellular tTGase was done as previously described (14) by stain-
ing cells in culture. Immunolabeling of tTGase was carried out using
anti-tTGase primary monoclonal antibody Cub7402 and fluorescein
isothiocyanate (FITC)-conjugated anti-mouse IgG secondary antibody.
Staining was visualized by confocal fluorescent microscopy using a
Leica TCSNT confocal laser microscope system (Leica Laserechnik,
Heidelberg, Germany).
Flow Cytometry—For flow cytometry, transfected Swiss 3T3 fibro-
blasts were detached from tissue culture dishes with 2 mM EDTA in
PBS, pH 7.4. Live non-permeabilized cells in suspension (2  106
cells/ml) were stained for cell-surface tTGase with anti-tTGase anti-
body Cub7402 (3 g/ml) in serum-free medium for 3 h at 4 °C. After
washing cells with serum-free medium and incubation with FITC-
conjugated anti-mouse IgG secondary antibody, cells were washed once
more, fixed in 0.5% (v/v) formaldehyde, and analyzed with a Dako
Galaxy flow cytometer. Values represent the mean fluorescence
intensity.
Statistical Analysis—Student’s t test was used to compare data.
When p was 0.05, the difference between sets of data was considered
to be statistically different.
RESULTS
Characterization of Swiss 3T3 Clones Transfected with Ac-
tive and Inactive C277S Mutant tTGases under the Control of
the Tetracycline-regulated System—The amount of tTGase an-
tigen expressed in cell homogenates of induced transfected cells
was detected by SDS-PAGE and Western blot analysis. The
Western blot shown in Fig. 1A shows clear induction of both
forms of the enzyme in TG3 and TGI19. Densitometric anal-
ysis indicated that expression of clone TG3 increased between
7- and 10-fold, as previously documented (14). For the inactive
C277S mutant, quantitation of induction by densitometry was
not possible because of the low endogenous background. Meas-
urement of antigen by a modified ELISA that first involves
attachment of the enzyme to a fibronectin-coated plate indi-
cated a 2–3-fold induction for clone TG3 and a 4–5-fold increase
for clone TG19. Overexpression of the active form of the enzyme
in clone TG3 led to an increase in total tTGase activity in cell
homogenates (12-fold) as measured by the [14C]putrescine
incorporation assay (Fig. 1C) and an increase in cell surface-
related extracellular activity (3–4-fold) as measured by the
cell-mediated incorporation of biotinylated cadaverine into fi-
bronectin (Fig. 1D) (14). As expected, no tTGase activity was
observed in clone TGI19 when induced to overexpress the in-
active form of the enzyme (Fig. 1, C and D).
Migratory Ability of Transfected Swiss 3T3 Fibroblasts on
Fibronectin—By the agarose droplet method (Fig. 2A), the
transfected clone TG3 overexpressing tTGase showed a de-
creased rate of cell migration on fibronectin compared with the
non-induced control (Fig. 2B), suggesting that increased ex-
pression of tTGase affects cell motility. A reduced rate of mi-
gration was also observed in clone TGI19 induced to overex-
press inactive tTGase compared with the non-induced cells
(Fig. 2B), indicating that cell motility is not dependent on the
cross-linking activity of tTGase. Interestingly, the reduction in
migration in the inactive and active clones reflected the rela-
tive amounts of induced tTGase present (see Fig. 1).
When left to migrate in the presence of a range of competitive
substrates of tTGase, the motility of TG3 cells was not signif-
icantly affected compared with that of untreated cells (Fig. 2C).
Similarly, cell motility was also not affected when the irrevers-
ible active site-specific inhibitor Rob283 (2-[(2-oxopropyl)thio]
imidazolium derivative) (38, 39) was used at a concentration of
FIG. 1. Characterization of Swiss
3T3 fibroblast clones TG3 and TGI19
displaying regulated expression of
tTGase. A, detection of tTGase antigen in
cell homogenates by SDS-PAGE analysis
and Western blotting. B, measurement of
tTGase antigen in cell homogenates by
the modified ELISA method. C, measure-
ment of tTGase activity by [14C]pu-
trescine incorporation into N,N-dimeth-
ylcasein. D, measurement of cell surface-
related tTGase activity by incorporation
of biotinylated cadaverine into fibronec-
tin. TG3 and TGI19 are clones induced
to overexpress active and inactive
tTGases, respectively, by removal of tet-
racycline from the culture medium, TG3
and TGI19 are non-induced controls
grown in tetracycline-containing medium.
Results represent means  S.D. from
three separate experiments.
Secretion and Role of tTGase in Cell Migration 16569
 by guest, on O
ctober 2, 2009
w
w
w
.jbc.org
D
ow
nloaded from
 
0.1 mM (IC50  50 M in our hands) (Fig. 2C), further suggest-
ing that the cross-linking activity of the enzyme is not respon-
sible for the observed effect of tTGase on cell migration.
To explore whether the intracellular or extracellular fraction
of tTGase was affecting cell motility, cell migration was as-
sessed in the presence of varying amounts of mouse anti-
tTGase monoclonal antibody Cub7402, which binds to cell-
surface tTGase as previously shown (13, 14). Addition of
Cub7402 to non-induced TG3 cells decreased the rate of fibro-
blast migration in a dose-dependent manner (Fig. 2D), and
migration was completely abolished at 0.1 mg/ml. Cells treated
with control mouse IgG showed a migration rate similar to that
of the untreated cells. This indicates that the major candidate
involved in migration is cell surface-related tTGase.
Attachment of Transfected Swiss 3T3 Fibroblasts—Cells in-
duced to overexpress tTGase (active and inactive C277S mu-
tant) demonstrated a small but significantly greater attach-
ment to fibronectin-coated surfaces than the non-induced
controls when cultured in serum-free medium (Fig. 3). This
effect was not observed when cells were seeded on tissue cul-
ture plastic in the presence of serum-containing medium (data
not shown).
Cellular Localization of tTGase in Transfected Cells—In view
of the findings shown in Figs. 2 and 3, it was important to
demonstrate that inactive C277S mutant tTGase has a subcel-
lular distribution comparable to that of the active wild-type
enzyme. To explore the subcellular distribution of tTGase in
the different transfected cells, cell homogenates were initially
fractionated by centrifugation, and the cytosolic and mem-
brane-rich fractions were analyzed by Western blotting. The
active form of the enzyme could be found in both the cytosolic
and membrane fractions of cells expressing endogenous levels
of enzyme (TG3) (Fig. 4). However, following induction, both
forms of the enzyme (TG3 and TGI19) could be detected in
the membrane and cytosolic fractions (Fig. 4).
Immunochemical staining of cells for matrix-associated
tTGase (14) indicated increased ECM-associated enzyme in
induced cells overexpressing the catalytically active form of the
enzyme. In contrast, cells displaying increased expression of
inactive C277S mutant tTGase showed levels of externalized
enzyme comparable to those of the non-induced cells or cells
incubated with nonimmune mouse IgG (Fig. 5A), suggesting
that this inactive form of the enzyme is not secreted and de-
posited into the ECM. Use of an ELISA-based method to quan-
tify extracellular tTGase (19) confirmed that an increased level
of ECM-associated tTGase could be detected only in cells over-
FIG. 3. Effects of tTGase on cell attachment. The number of cells
attached in 30 min to fibronectin-coated surfaces was measured by
staining cells with crystal violet as described under “Experimental
Procedures.” TG3 and TGI19 are clones induced to overexpress active
and inactive tTGases, respectively; TG3 and TGI19 are non-induced
controls. Results represent means  S.D. from three separate experi-
ments. *, significant difference (p  0.05) between induced clones and
non-induced controls.
FIG. 4. Western blot analysis of the cellular distribution of
tTGase in transfected clones. TG3 and TGI19 are clones induced
to overexpress active and inactive tTGases, respectively; TG3 and
TGI19 are non-induced controls. Cells were fractionated into mem-
brane-rich (M) and cytosolic (C) fractions as described under “Experi-
mental Procedures.”
FIG. 2. Migration of transfected
Swiss 3T3 fibroblasts. A, an example of
outwardly migrating cells from an aga-
rose droplet. B, quantification of the mi-
gration of fibroblasts expressing different
levels of catalytically active and inactive
tTGases. C, effect of tTGase inhibitors (10
mM putrescine, 1 mM cystamine, 0.05 mM
monodansylcadaverine, 2 mM methyl-
amine, and 0.1 mM Rob283) on the migra-
tion of clone TG3. D, effect of anti-
tTGase antibody on the migration of cells
from clone TG3 treated with increasing
concentrations (mg/ml) of Cub7402 (shad-
ed bars) or control nonspecific mouse IgG
(hatched bars). TG3 and TGI19 are
clones induced to overexpress active and
inactive tTGases, respectively; TG3 and
TGI19 are non-induced controls. Results
represent means  S.D. from three inde-
pendent experiments. *, significant differ-
ence (p  0.05) between induced clones
and non-induced controls.
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expressing the active form of the enzyme and not in cells
overexpressing the inactive form of tTGase compared with
non-induced cells (Fig. 5B).
Western blot analysis of both induced clones TG3 and
TGI19 showed an increased presence of active and inactive
tTGases, respectively, in the cell membrane fraction. The pres-
ence of both forms of tTGase on the cell surface was confirmed
by immunoprobing the cell surface, followed by flow cytometry
analysis. These results showed that induced cells overexpress-
ing both active and inactive C277S mutant tTGases had in-
creased levels of surface enzyme compared with their non-
induced controls (Fig. 6). The relative amount of enzyme on the
cell surface appeared to be comparable to the total level of
enzyme present in the clones (see Fig. 1).
Detection of tTGase in the Cell Growth Medium—Because
the inactive C277S mutant enzyme may be deposited into the
cell culture medium rather than the ECM, the cell growth
medium was also analyzed. To avoid the binding of external-
ized tTGase to serum fibronectin, cells were incubated in se-
rum-free AIMV medium for 8 h prior to analysis of tTGase
antigen. Analysis of proteins precipitated from the growth me-
dium by Western blotting indicated the presence of tTGase
antigen in the medium of clone TG3, induced to express the
active form of the enzyme (Fig. 7A). In contrast, tTGase could
not be detected in the medium of the non-induced cells (TG3
and TGI19) or cells overexpressing the inactive C277S mu-
tant form of the enzyme (TGI19) (Fig. 7A). This result was
confirmed when the cell growth medium was analyzed by the
modified ELISA (Fig. 7B).
Characterization of Swiss 3T3 Clones Transfected with Ac-
tive and Inactive Y274A Mutant tTGases—Our data so far
indicate that transglutaminase activity and/or an active-site
region containing a Cys277 rather than a Ser277 mutation is
required for externalization of the enzyme into the surrounding
matrix. Recent studies (6) have shown that also present in this
active-site region of tTGase at Tyr274 is a peptide bond held in
the cis conformation, and not in the favored trans conforma-
tion. Given the closeness of this cis peptide bond to the active-
site Cys277, there is the possibility that mutation of Cys277 to
Ser could affect this cis conformation as well as nullify trans-
glutaminase activity. The question therefore arises whether
the mutation of Tyr274, which stabilizes the cis peptide bond
conformation (6), to Ala274 also affects externalization of the
enzyme. To address this question, codon 274 of the tTGase
cDNA was mutated to encode Ala by site-directed mutagenesis,
and the Y274A mutant and wild-type cDNAs were then stably
expressed in Swiss 3T3 fibroblasts. Analysis of the expressed
enzyme in transfected clones by Western blotting (Fig. 8A) and
by the modified ELISA (Fig. 8B) indicated that the tTGase-
transfected clones (wild-type TG1 and TG16 and Y274A mu-
tant TGY274A1 and TGY274A2) showed increased amounts of
FIG. 5. Detection of the extracellular pool of tTGase in trans-
fected 3T3 fibroblasts. A, immunofluorescent staining of extracellu-
lar tTGase in cultured transfected fibroblasts. The Cub7402 antibody or
nonimmune mouse IgG was added to live cell cultures, and the immu-
nofluorescence of FITC-conjugated secondary antibody was detected by
confocal microscopy as described under “Experimental Procedures.”
Bar 50 m. B, measurement of ECM-associated tTGase by a modified
ELISA as described under “Experimental Procedures.” TG3 and
TGI19 are clones induced to overexpress active and inactive tTGases,
respectively; TG3 and TGI19 are non-induced controls. Absorbance
levels were normalized to 1 mg of deoxycholate-extracted protein. Re-
sults represent means  S.D. from three separate experiments. *,
significant difference (p  0.05) between induced clones and non-in-
duced controls.
FIG. 6. Analysis of the cell-surface enzyme found in trans-
fected clones by flow cytometry. Cells were detached with EDTA
and incubated in suspension with primary antibody Cub7402, followed
by incubation with FITC-conjugated secondary antibody as described
under “Experimental Procedures.” TG3 and TGI19 are clones in-
duced to overexpress active and inactive tTGases, respectively; TG3
and TGI19 are non-induced controls. Mouse IgG was used as the
isotype control and for setting of the background gate.
FIG. 7. Measurement of tTGase in serum-free AIMV cell cul-
ture medium after an 8-h incubation. A, Western blot showing the
presence of tTGase in the cell culture medium after precipitation of
proteins with trichloroacetic acid as described under “Experimental
Procedures.” B, measurement of tTGase antigen in 10 concentrated
AIMV serum-free cell culture medium by a modified ELISA as de-
scribed under “Experimental Procedures.” TG3 and TGI19 are clones
induced to overexpress active and inactive tTGase respectively; TG3
and TGI19 are non-induced controls. AIM V, 10 concentrated serum-
free AIMV cell culture medium; TGstd, guinea pig liver transglutami-
nase standard. Results represent means  S.D. from three separate
experiments. *, significant difference (p  0.05).
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tTGase expression compared with the transfected negative con-
trols (neo1 and neo3 expressing the selection vector pSV2neo
only). The Y274A mutation did not affect binding to fibronectin,
as the active and inactive mutant tTGases showed comparable
fibronectin-binding abilities (Fig. 8B) in the modified ELISA.
Overexpression of the active form of the enzyme in clones TG1
and TG16 led to an increase in tTGase activity in total cell
homogenates (Fig. 8C) and an increase in cell surface-related
extracellular activity (Fig. 8D). However, as expected (6), the
mutation at position 274 diminished tTGase activity in clones
TGY274A1 and TGY274A2, comparable to that in the transfected
negative controls (neo1 and neo3) (Fig. 8, C and D).
Cellular Localization and Externalization of Y274A Mutant
tTGase—To investigate the effect of the Y274A mutation on
enzyme externalization, the transfected clones were first frac-
tionated by centrifugation, and cytosolic and membrane-rich
fractions were analyzed by Western blotting. The active and
inactive Y274A mutant forms of the enzyme could be found in
both the cytosolic and particulate fractions of cells, but the
mutant form of tTGase showed a smaller amount of enzyme
associated with the cell membrane fraction compared with
active tTGase (Fig. 9).
Transfected clones were also immunoprobed for the presence
of tTGase on the cell surface and analyzed by flow cytometry.
In keeping with the fractionation studies (Fig. 9), clones ex-
pressing the active form of tTGase (TG1 and TG16) showed
increased amounts of cell-surface enzyme compared with the
transfected negative controls (neo1 and neo3) (Fig. 10). Clones
transfected with Y274A mutant tTGase (TGY274A1 and
TGY274A2) showed only a small increase in the amount of cell-
surface enzyme compared with the transfected negative con-
trols (neo1 and neo3) (Fig. 10). Unlike active tTGase, the
Y274A mutant form of tTGase could not be detected in the cell
growth medium (Fig. 11) when analyzed by Western blotting,
indicating that it is unlikely to be secreted from cells.
DISCUSSION
The functional role played by tTGase in cell migration has
never been clearly established despite observations indicating
that tTGase is involved in cell adhesion (14, 15, 29, 41). In this
report, our objective was to ascertain whether the enzyme’s
effect on cell migration was due to its cross-linking activity, its
action as a cell-surface binding protein, and/or its ability to act
as a GTP-binding protein. The model used involved cell lines of
Swiss 3T3 fibroblasts expressing catalytically active or inactive
C277S mutant tTGase in a tetracycline-regulated manner. We
have previously shown that this model allows maximum ex-
pression of tTGase following a 72-h period of induction (14, 19,
23). It does not suffer from clonal variation because each clone
acts as its own control when induced; moreover, it gives homo-
geneous enzyme expression unlike the heterogeneous expres-
sion and low transfection efficiency often associated with tran-
sient transfection models.
In transfected cells induced to express catalytically active
tTGase (clone TG3), the activity of tTGase was increased in cell
homogenates and at the cell surface of the cells, confirming
that increased expression of tTGase leads to increased exter-
nalization of the enzyme as previously found (14). Following
induction of catalytically inactive C277S mutant tTGase in
clone TGI19, the tTGase activity of cell homogenates remained
unchanged, as expected. The relative measure of the ability of
the C277S mutant and wild-type proteins in the transfected
cell lines to associate with the substrate fibronectin was found
to be comparable. This is a significant result in support of our
additional investigations, as we have recently shown that bind-
ing of tTGase to fibronectin is crucial for enzyme cell-surface
localization (23). We demonstrated that fibroblasts induced to
overexpress active and inactive forms of tTGase showed a de-
creased rate of migration on fibronectin, which was accompa-
nied by enhanced cell attachment, suggesting that the cross-
linking activity of tTGase is not responsible for the enzyme’s
effects on cell motility. This observation was confirmed by the
inability of inhibitors of tTGase activity to affect cell migration.
One of these inhibitors, the irreversible inhibitor Rob283, led to
90% inhibition of cell surface-related tTGase activity when
used at 100 M (data not shown). However, the ability of anti-
tTGase monoclonal antibody Cub7402 to reduce cell migration
FIG. 9. Western blot analysis of the cellular distribution of
tTGase in transfected clones. Cells were fractionated into mem-
brane-rich (M) and cytosolic (C) fractions as described under “Experi-
mental Procedures.” TG1 and TG16 are clones transfected with active
wild-type tTGase; TGY274A1 and TGY274A2 are clones transfected with
inactive Y274A mutant tTGase; and neo1 and neo3 are transfected
negative controls.
FIG. 8. Characterization of Swiss
3T3 clones transfected with active
and inactive Y274A mutant tTGases.
A, detection of tTGase antigen in cell ho-
mogenates by SDS-PAGE analysis and
Western blotting. B, measurement of
tTGase antigen in cell homogenates by
the modified ELISA method. C, measure-
ment of tTGase activity by [14C]pu-
trescine incorporation into N,N-dimeth-
ylcasein. D, measurement of cell surface-
related tTGase activity by incorporation
of biotinylated cadaverine into fibronec-
tin. TG1 and TG16 are clones transfected
with active wild-type tTGase; TGY274A1
and TGY274A2 are clones transfected with
inactive Y274A mutant tTGase; and neo1
and neo3 are transfected negative con-
trols. Results for A, C, and D represent
means  S.D. from three separate
experiments.
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in a dose-dependent manner indicates that the cell-surface
enzyme is an essential component in the migration of cells.
Complete loss of cell motility at 100 g/ml Cub7402 could be
explained by earlier findings indicating that the binding of the
antibody to cell-surface tTGase completely inhibits cell attach-
ment to fibronectin (14). As a consequence, cell movement is
not possible without cell attachment. This ability of anti-
tTGase antibodies to block both cell attachment and cell mi-
gration is comparable to the outcome observed when cells are
incubated with antibodies directed against the cell-surface re-
gion of the 1- and 5-integrins (42). Integrin ligand-binding
properties are thought to govern cell migration speed through
the degree of cell-substratum adhesiveness (43). The data re-
ported here indicate that the effects of tTGase on the migration
of fibroblasts are brought about by a similar mechanism. Our
studies on cell attachment to fibronectin show that overexpres-
sion of tTGase (active and inactive forms), which was accom-
panied by a decreased rate of cell migration, led to a small but
significant increase in cell adhesiveness. Previous work has
also demonstrated that changes in expression of tTGase in NIH
3T3 fibroblasts (44), fibrosarcoma cells (45), and endothelial
like cells (13) can lead to similar changes in cell adhesion.
Using immunogold electron microscopy, we have recently
provided evidence for a preferential extracellular location of
tTGase in dense clusters close to the cell surface/pericellular
matrix and in association with fibronectin (23). It is therefore
possible that tTGase might be involved in cell attachment and
migration as a cell-surface binding protein. In agreement with
our data, Akimov et al. (15) recently reported that the adhesive
function of tTGase does not require its cross-linking activity,
but is thought to be dependent on its stable noncovalent asso-
ciation with integrins. A close association of tTGase with 1-
integrin was also demonstrated by Gaudry et al. (21) in the
early stages of cell attachment by immunofluorescent staining.
However, in this case, the localization became less prominent
as cells spread more. Therefore, tTGase could function as a
cell-surface molecule independent of its catalytic activity, di-
rectly through its close association with fibronectin (23), or by
interacting with the integrin cell-surface receptors (15), pro-
moting cell interaction with the matrix and therefore slowing
down cell migration. Alternatively, tTGase could still act as a
GTP-binding protein in controlling cell migration (the C277S
mutant retains GTP-binding activity), although the ability of
cell surface-directed anti-tTGase antibodies to block migration
strongly suggests it to be a cell-surface event.
In previous work using 96-h-old cultures of Swiss 3T3 cells
induced to overexpress tTGase, we reported a clear increase in
-(-glutamyl)lysine cross-links, the majority of which are
likely to be present in the ECM (14). It may therefore be
plausible that tTGase contributes early to cell adhesion, acting
from the cell surface independent of its cross-linking activity;
but once released in the extracellular space, possibly by a
“piggyback” mechanism via its binding to fibronectin, it starts
to accumulate and in doing so contributes to the cross-linking
of ECM proteins when and if appropriate substrates become
available. This suggests that stabilization of ECM proteins by
tTGase is more of a “long-term” process as a result of the
progressive accumulation of secreted tTGase and availability of
substrate proteins rather than an immediate event capable of
mediating cell adhesion and migration. However, in a patho-
logical situation such as in a wounded area, an increased
amount of tTGase might also be deposited into the matrix as a
result of increased expression of the enzyme (10) or as a result
of leakage following cell stress (28) or cell death and exert its
cross-linking-mediated role of matrix stabilizer directly, thus
contributing to the maintenance of tissue integrity.
Important to the hypothesis that a cell surface-related
tTGase (active or inactive) can mediate changes in cell migra-
tion is that both the active and inactive C277S mutant enzymes
have similar cellular distributions and that mutation of the
enzyme does not affect this distribution. Our data show that
both forms of tTGase were detected at the cell surface. How-
ever, only cells overexpressing the catalytically active form of
tTGase showed increased and detectable amounts of tTGase
antigen deposited into the ECM and culture medium. This
novel finding indicates that only cell surface-associated tTGase
and not tTGase deposited into the matrix is required to affect
the cell migratory process; moreover, this function of tTGase
does not require cross-linking activity. Our preliminary studies
have indicated so far that incubation of cells with the active
site-directed inhibitor Rob283 or the competitive primary
FIG. 10. Analysis of the cell surface-related enzyme in cells
transfected with the Y274A mutant and the respective controls
by flow cytometry. Cells were detached with EDTA and incubated in
suspension with primary antibody Cub7402, followed by incubation
with FITC-conjugated secondary antibody as described under “Experi-
mental Procedures.” TG1 and TG16 are clones transfected with active
wild-type tTGase; TGY274A1 and TGY274A2 are clones transfected with
inactive Y274A mutant tTGase; and neo1 and neo3 are transfected
negative controls. Labeling with mouse IgG was used as the isotype
control and for setting the background gate.
FIG. 11. Detection of active wild-type and inactive Y274A mu-
tant tTGases in serum-free AIMV cell culture medium after an
8-h incubation. A Western blot shows the presence of tTGase in
serum-free AIMV cell culture medium after precipitation of proteins
from the medium with trichloroacetic acid as described under “Exper-
imental Procedures.” TG1 and TG16 are clones transfected with active
wild-type tTGase; TGY274A1 and TGY274A2 are clones transfected with
inactive Y274A mutant tTGase.
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amine cystamine did not significantly reduce the amount of
enzyme deposited into the matrix (data not shown). This
initially suggests that the cross-linking activity of the en-
zyme is not required for the complete secretory process. How-
ever, these inhibitors may not access the active site until the
enzyme is in its Ca2-mediated active conformation, which is
when the enzyme is already at the cell surface. We therefore
cannot rule out that the active-site Cys277 has two important
roles in the secretory mechanism: one that is essential to the
folding of the protein to achieve a conformation necessary for
the secretion and the other in the cross-linking mechanism of
the enzyme.
Recently, on the basis of crystallographic studies of Factor
XIIIa, a novel mechanism for transglutaminase activation
has been proposed based on the identification of two non-
proline cis peptide bonds, which are thought to act as a
conformational switch between catalytically active/inactive
states of transglutaminase (6). In Factor XIIIa, one of these
bonds is thought to be necessary for close association of the
two active a subunits, whereas the other is close to the
active-site cysteine. According to this work, the conforma-
tional rearrangements necessary to expose the hidden active
site would depend on the cis-to-trans isomerization of these
peptide bonds, which may be linked to substrate, or calcium
binding. The fact that these bonds are very rare in protein
structures (46) and that one of them is found close to the
active site, which is a highly conserved region among trans-
glutaminases, strongly suggests a functional role for them.
We therefore transfected Swiss 3T3 cells with tTGase in
which the potential tTGase cis peptide close to the active-site
region at position 274 was mutated from Tyr to Ala (Y274A).
Analysis of these transfected cells indicated that the Y274A
mutation abolished the activity of tTGase in both clones
examined, as previously predicted (6). Comparison of wild-
type clone TG16 and mutant clone TGY274A2, which express
similar amounts of total enzyme, indicated that both the
active and inactive Y274A mutant forms of the enzyme could
be found in the membrane-rich and cytosolic fractions of the
cells; however, cells expressing the mutant form of tTGase
showed lower levels of membrane-associated enzyme. Meas-
urement of cell-surface tTGase by flow cytometry confirmed
that the clones expressing the Y274A mutant form of the
enzyme had relatively small amounts of cell-surface tTGase,
although the levels were greater than those in the trans-
fected negative controls (neo1 and neo3). The Y274A muta-
tion was also found to prevent secretion of the enzyme into
the cell culture medium.
Our data therefore show that mutations in the Cys277 active-
site region of the enzyme and at Tyr274, which lies in a newly
predicted non-proline cis peptide bond region thought to be
critical for the exposure of the enzyme active site, both lead to
loss of cross-linking activity. We also demonstrate that the
conformation of this active-site region of the enzyme or possibly
the cross-linking activity of the enzyme is a major factor in the
mechanism that governs the secretion and deposition of the
enzyme into the ECM. Hence, secretion of the enzyme may be
connected to the cis-to-trans isomerization of the non-proline
cis peptide bonds. We hypothesize that the active trans confor-
mation may occur in the enzyme upon the binding of Ca2 and
substrate. This process would occur once the enzyme reaches
the cell surface, where both Ca2 and substrates such as fi-
bronectin are available to the enzyme. Interestingly, we have
recently reported that the fibronectin-binding site in the N-
terminal -sandwich domain of tTGase is also important in the
secretion mechanism of this enzyme (23).
In conclusion, this work shows the importance of cell-
surface tTGase in the regulation of cell migration. This novel
function of the enzyme does not require tTGase catalytic
activity and can be correlated with a tTGase-mediated in-
crease in cell adhesion strength. We have also demonstrated
for the first time that the active-site cysteine and the tertiary
structure of the active-site region, including a putative non-
proline cis peptide bond, are key players in determining
enzyme secretion.
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